Convenientcomma; Nonradioactivecomma; Heteroduplexhyphen;based Methods for Identifying Recurrent Mutations in the BRCA1 and BRCA2 Genes

摘要

The ability to identify inviduals who are predisposed to specific malignant tumors is a promising molecular diagnostic byproduct of over two decades of intensive research into the genetic pathogenesis of human cancer. Approximately 2percnt; of Ashkenazi Jews carry recurrent germline mutations in either the BRCA1 or BRCA2 genes that may predispose these individuals to the development of breast and ovarian cancer. We have developed a nonisotopic method, based on the formation of heteroduplexes between polymerase chain reaction (PCR) amplified wild-type and mutant alleles, which can be used to identify the BRCA1 185delAG and the BRCA2 6174delT mutations. The same assay can also be used to verify the loss of heterozygosity in a tumor sample arising in an individual with a germline mutation. The four steps described in this report (PCR amplification, heteroduplex formation, acrylamide gel electrophoresis, and ethidium bromide staining/UV-fluorescence photography) can be readily and reproducibly performed in the course of a single day, making this a useful method for the routine identification of these mutations.